Utah Medical Products (UTMD) Upgraded at BidaskClub
Utah Medical Products (NASDAQ:UTMD) was upgraded by investment analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued on Wednesday.
Shares of Utah Medical Products (NASDAQ:UTMD) opened at $86.45 on Wednesday. The stock has a market capitalization of $321.51, a PE ratio of 23.49 and a beta of 0.77. Utah Medical Products has a 12-month low of $58.50 and a 12-month high of $94.00.
Utah Medical Products (NASDAQ:UTMD) last issued its quarterly earnings results on Tuesday, January 30th. The medical instruments supplier reported $0.95 earnings per share (EPS) for the quarter. The firm had revenue of $10.20 million during the quarter. Utah Medical Products had a return on equity of 18.92% and a net margin of 20.54%.
About Utah Medical Products
Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.